Biden Administration Buys 600,000 Treatments Courses of New COVID Antibody Drug That ‘Works Against Omicron Variant’

7 months ago
The Biden administration has purchased 600,000 treatments courses of a new COVID-19 monoclonal antibody drug that data shows works against the omicron variant of the CCP (Chinese Communist Party) virus. Known as bebtelovimab, the drug is manufactured by Eli Lilly and Company, an American pharmaceutical company headquartered in Indianapolis, Indiana. It is used in the treatment of mild to moderate COVID-19 in certain high-risk patients and works via laboratory-made proteins th...
Read Entire Article